Treatment of Chlamydia trachomatis Infection
Treat chlamydia with doxycycline 100 mg orally twice daily for 7 days as first-line therapy, or azithromycin 1 g orally as a single dose when compliance with multi-day dosing is uncertain.
Recommended First-Line Regimens
The standard treatment options are equally effective 1:
- Doxycycline 100 mg orally twice daily for 7 days
- Azithromycin 1 g orally as a single dose
Both regimens achieve microbial cure rates of 97-98% and are equally efficacious 1, 2. However, the choice between them depends on clinical context:
When to Choose Doxycycline
- For rectal chlamydia infections: Doxycycline is significantly more effective than azithromycin for rectal infections, with evidence showing a 16.9% greater reduction in recurrent/persistent infections 3
- When cost is a consideration: Doxycycline costs less than azithromycin with no higher risk for adverse events 1
- Recent guideline preference: The 2025 European guideline recommends doxycycline as first-line in preference to azithromycin 4
When to Choose Azithromycin
- Poor compliance anticipated: Single-dose directly observed therapy is ideal for patients with erratic healthcare-seeking behavior or unpredictable follow-up 1
- Immediate treatment needed: Enables complete treatment in one clinic visit
- Multi-day dosing not feasible: Azithromycin should always be available for patients where compliance with 7-day regimens is questionable 1
Alternative Regimens
If first-line options are contraindicated 1:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
Important caveat: Erythromycin may be less efficacious due to gastrointestinal side effects that discourage compliance 1. Fluoroquinolones are effective but more expensive with no dosing advantage 1.
Critical Management Points
Medication Dispensing
- Dispense medications on-site and directly observe the first dose to maximize compliance 1
- This approach minimizes transmission and ensures treatment initiation
Sexual Abstinence Instructions
Patients must abstain from sexual intercourse 1:
- For 7 days after single-dose azithromycin
- Until completion of the full 7-day doxycycline course
- Until all sex partners are treated to minimize reinfection risk
Partner Treatment
Treating sex partners is essential to prevent reinfection of the index patient and transmission to others 1. The majority of post-treatment infections result from untreated partners or new infected partners 1.
Follow-Up Considerations
Test-of-Cure
Not routinely recommended except in pregnant women, unless 1:
- Therapeutic compliance is questionable
- Symptoms persist
- Reinfection is suspected
Critical timing: Do not test <3 weeks after completing therapy, as this can yield false results due to persistent dead organisms or limited viable organisms 1.
Retesting for Reinfection
Women should be retested approximately 3 months after treatment due to high prevalence of reinfection (not treatment failure) 1. Repeat infections confer elevated risk for pelvic inflammatory disease and complications compared to initial infection 1.
Common Pitfalls to Avoid
- Testing too early post-treatment: Wait at least 3 weeks to avoid false-positive results from dead organisms 1
- Using azithromycin for rectal infections: Recent evidence strongly favors doxycycline for this site 3
- Failing to treat partners: This is the primary cause of reinfection 1
- Not considering compliance: Match the regimen to the patient's ability to complete multi-day therapy 1